Cubist Systematic Strategies LLC Sells 38,155 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Cubist Systematic Strategies LLC lessened its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 10.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 327,042 shares of the company’s stock after selling 38,155 shares during the period. Cubist Systematic Strategies LLC’s holdings in Privia Health Group were worth $5,684,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Privia Health Group by 8.5% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock worth $134,000 after acquiring an additional 605 shares during the period. Arizona State Retirement System increased its position in Privia Health Group by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock worth $462,000 after purchasing an additional 617 shares in the last quarter. Signaturefd LLC increased its position in Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after purchasing an additional 626 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in Privia Health Group by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock worth $176,000 after purchasing an additional 756 shares in the last quarter. Finally, Parkside Financial Bank & Trust increased its position in Privia Health Group by 9.7% during the 2nd quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company’s stock worth $151,000 after purchasing an additional 771 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

Insider Buying and Selling

In related news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now owns 247,771 shares in the company, valued at $4,583,763.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 14.20% of the stock is currently owned by corporate insiders.

Privia Health Group Price Performance

Shares of PRVA stock opened at $18.08 on Friday. The firm has a 50-day moving average of $19.46 and a 200-day moving average of $18.55. The company has a market cap of $2.16 billion, a P/E ratio of 120.53, a P/E/G ratio of 4.32 and a beta of 0.77. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.35.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.02). The firm had revenue of $422.30 million during the quarter, compared to analysts’ expectations of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The business’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.06 EPS. As a group, research analysts expect that Privia Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on PRVA shares. Royal Bank of Canada reiterated an “outperform” rating and set a $28.00 price objective on shares of Privia Health Group in a research report on Wednesday, August 14th. Evercore ISI lowered their price objective on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. Finally, Robert W. Baird upped their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. Two research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Privia Health Group presently has an average rating of “Moderate Buy” and an average target price of $24.86.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.